LEGN
$28.13
Revenue | $272.33Mn |
Net Profits | $-39.69Mn |
Net Profit Margins | -14.57% |
Legend Biotech Corp’s revenue jumped 69.99% since last year same period to $272.33Mn in the Q3 2025. On a quarterly growth basis, Legend Biotech Corp has generated 6.77% jump in its revenue since last 3-months.
Legend Biotech Corp’s net profit jumped 68.33% since last year same period to $-39.69Mn in the Q3 2025. On a quarterly growth basis, Legend Biotech Corp has generated 68.35% jump in its net profits since last 3-months.
Legend Biotech Corp’s net profit margin jumped 81.37% since last year same period to -14.57% in the Q3 2025. On a quarterly growth basis, Legend Biotech Corp has generated 70.35% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.03 |
EPS Estimate Current Year | -0.03 |
Legend Biotech Corp’s earning per share (EPS) estimates for the current quarter stand at -0.03 - a 70.92% jump from last quarter’s estimates.
Legend Biotech Corp’s earning per share (EPS) estimates for the current year stand at -0.03.
Earning Per Share (EPS) | 0 |
Legend Biotech Corp’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Legend Biotech Corp has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-11 | -0.12 | 0.03 | 125% |
2025-11-12 | -0.03 | 0 | 100% |
2025-05-13 | -0.25 | -0.54 | -112.6% |